Vanda Pharmaceuticals Inc. (VNDA)

Last Closing Price: 4.34 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Vanda Pharmaceuticals Inc. (VNDA) had Net Income of $-18.90M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$198.77M
Net Income
$-18.90M
$11.31M
$187.46M
$239.43M
$-40.66M
$17.74M
$-22.92M
$-22.92M
$-18.90M
$-18.90M
$-18.90M
$-18.90M
$-40.66M
$-39.52M
58.15M
58.15M
$-0.33
$-0.33
Balance Sheet Financials
$438.89M
$2.13M
$217.31M
$656.20M
$99.98M
--
$17.68M
$117.66M
$538.55M
$424.45M
$538.55M
58.31M
Cash Flow Statement Financials
$-15.76M
$-17.43M
$-0.15M
$136.29M
$102.78M
$-33.51M
$12.43M
--
--
Fundamental Metrics & Ratios
4.39
--
--
--
--
94.31%
-20.46%
-20.46%
-19.88%
-11.53%
-9.51%
$-20.48M
--
--
--
0.30
6.55
4.22
86.49
-3.51%
-4.45%
-2.88%
-3.51%
$9.24
$-0.35
$-0.27